Latest Updates Around The World
India’s benchmark indices Sensex and Nifty closed lower on Friday as investors cut positions near record highs, while thin year-end trading and continued foreign outflows dampened risk appetite. The pullback capped a subdued session marked by light participation and selective selling among index heavyweights.The BSE Sensex fell 367 points or 0.4% to end at 85,041.45, […]
Markets traded dull for the second straight session on Wednesday, ending marginally lower, indicating continued consolidation after the recent surge. Analysts maintain a positive bias amid the ongoing consolidation in the index and continue to recommend a buy-on-dips approach as long as the Nifty maintains its prevailing uptrend.“For renewed momentum, stronger participation from the banking […]
Indian shares ended flat on Friday with a negative bias, with the Sensex and Nifty swinging between red and green as investors locked in gains near record levels and weighed expectations of possible rate cuts in both the US and India alongside incoming domestic growth signals.The S&P BSE Sensex fell 13.7 points, or 0.02%, to […]
Indian benchmark indices gave up early morning gains to end lower on Monday even as IT stocks had a good run on expectations of the Federal Reserve’s December rate cut. The 30-share Sensex fell 331 points or 0.39%, while the broader Nifty index fell 0.4% to settle below 26,000. Analysts said Nifty is seeing repeated […]
Indian shares closed solidly higher on Wednesday, with the Sensex and Nifty paring early losses, as renewed foreign inflows and a recovery in IT big names kept sentiment steady. Infosys led the charge, anticipating its Rs 18,000 crore share buyback that will start on Thursday.The S&P BSE Sensex rose 513 points, or 0.61%, to close […]
Shares of AstraZeneca Pharma India rose as much as 3.5% to a day’s high of Rs 9,469.50 per share on the NSE on Tuesday, November 18, after the drugmaker said it has entered into a second brand partnership with Sun Pharmaceutical Industries to expand the availability of sodium zirconium cyclosilicate (SZC), a treatment used to […]
Drug giant Sun Pharmaceutical Industries on Wednesday reported a net profit after tax of Rs 3,117.95 crore for the second quarter of FY26, a growth of 2.6% year-on-year compared to a profit of Rs 3,040.16 crore in the year-ago period.The company said operating revenue for the second quarter ended September 2025 stood at Rs 14,405.22 […]
Sun Pharma is expected to show steady but moderate growth in its September second quarter (Q2 FY26) earnings, with analysts highlighting a combination of factors: a high base effect from last year’s Revlimid sales, weak performance at Taro and early-stage spending on the US launch of Leqselvi, the recently approved specialty drug.According to average broker […]
The pharmaceutical sector of India may not be in the headlines, but tariff -related uncertainties remain an important care for investors, says MarktExpert Sudip Bandyopadhyay. “Rate is the greatest uncertainty. Apart from Sun Pharma, most companies are not affected by the current American tariff regime. Even Sun will even avoid the bullet with recent developments. […]
The decision of the US government to impose a rate of 100% on imported patented medicines from 1 October could weigh on Sun Pharmaceutical Industries, the only major Indian drugstore with considerable exposure to innovative therapies in the US, HSBC said in a report of 26 September. The rate, which excludes companies that build factories […]
